Related Experiment Video
Updated: Feb 16, 2026

Single-Molecule Fluorescence Visualization of DNA Polymerase Dynamics at G-Quadruplexes
Published on: April 4, 2025
Family A and B DNA Polymerases in Cancer: Opportunities for Therapeutic Interventions
Vinit Shanbhag1,2, Shrikesh Sachdev3,4, Jacqueline A Flores5,6
1Department of Biochemistry, University of Missouri, Columbia, MO 65211, USA. vcs36d@mail.missouri.edu.
Abstract:
DNA polymerases are essential for genome replication, DNA repair and translesion DNA synthesis (TLS). Broadly, these enzymes belong to two groups: replicative and non-replicative DNA polymerases. A considerable body of data suggests that both groups of DNA polymerases are associated with cancer. Many mutations in cancer cells are either the result of error-prone DNA synthesis by non-replicative polymerases, or the inability of replicative DNA polymerases to proofread mismatched nucleotides due to mutations in 3'-5' exonuclease activity. Moreover, non-replicative, TLS-capable DNA polymerases can negatively impact cancer treatment by synthesizing DNA past lesions generated from treatments such as cisplatin, oxaliplatin, etoposide, bleomycin, and radiotherapy. Hence, the inhibition of DNA polymerases in tumor cells has the potential to enhance treatment outcomes. Here, we review the association of DNA polymerases in cancer from the A and B families, which participate in lesion bypass, and conduct gene replication. We also discuss possible therapeutic interventions that could be used to maneuver the role of these enzymes in tumorigenesis.
Insights
DNA polymerases are crucial for DNA replication and repair. Inhibiting these enzymes, particularly non-replicative DNA polymerases involved in cancer, may improve cancer treatment outcomes.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- DNA polymerases are vital for genome replication, DNA repair, and translesion DNA synthesis (TLS).
- Both replicative and non-replicative DNA polymerases are implicated in cancer development and progression.
- Mutations in cancer cells can arise from error-prone synthesis by non-replicative polymerases or impaired proofreading by replicative polymerases.
Purpose of the Study:
- To review the association of DNA polymerases (families A and B) with cancer.
- To discuss the role of these enzymes in lesion bypass and gene replication in tumorigenesis.
- To explore potential therapeutic strategies targeting DNA polymerases in cancer treatment.
Main Methods:
- Literature review of studies on DNA polymerases in cancer.
- Analysis of the mechanisms by which DNA polymerases contribute to cancer.
- Discussion of therapeutic interventions targeting DNA polymerases.
Main Results:
- Non-replicative DNA polymerases can introduce mutations and confer resistance to cancer therapies.
- Inhibition of DNA polymerases shows potential for enhancing cancer treatment efficacy.
- DNA polymerases from families A and B are key players in lesion bypass and replication.
Conclusions:
- Targeting DNA polymerases presents a promising therapeutic avenue for cancer treatment.
- Understanding the dual role of DNA polymerases in cancer is critical for developing effective strategies.
- Further research into modulating DNA polymerase activity could lead to improved patient outcomes.
More Related Videos
Related Concept Videos
Translesion DNA Polymerases
TLS polymerases are found in all three domains of life - archaea, bacteria, and eukaryotes. Of the different classes of TLS polymerases, members of the Y family are fitted with specialized structures that...
Gene Families
Occasionally these regions can be adapted to take on new roles within the organism, becoming novel genes...
Gene Families
Protein Families
Protein Families
Bacterial RNA Polymerase
In most genes, the transcription site is a single base present upstream of the coding sequence. Though RNAP is a catalytically efficient enzyme, it does not recognize...

